Fatigue and health-related quality of life in inflammatory bowel disease: Results from a population-based study in the Netherlands: The IBD-South Limburg cohort

Inflammatory Bowel Diseases

Volumn 16, Issue 12, 2010, Pages 2137-2147

  Romberg Camps, M J L ^a   Bol, Y ^a,b   Dagnelie, P C ^c   Hesselink Van De Kruijs, M A M ^a   Kester, A D M ^c   Engels, L G J B ^b   Van Deursen, C ^b   Hameeteman, W H A ^a   Pierik, M ^a   Wolters, F ^d   Russel, M G V M ^e   Stockbrugger R W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Zuyderland Medical Centre   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d Department of Gastroenterology   (Netherlands)

^e MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

fatigue; health related quality of life; inflammatory bowel disease; population based

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; CROHN DISEASE; DISEASE ACTIVITY; DYSTHYMIA; ENTERITIS; FATIGUE; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; YOUNG ADULT;

EID: 78649608764     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21285     Document Type: Article

References (84)

1. Swain MG,. Fatigue in chronic disease. Clin Sci (Lond). 2000; 99: 1-8.
2. Pittion-Vouyovitch S, Debouverie M, Guillemin F, et al. Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci. 2006; 243: 39-45.
3. Thombs BD, Bassel M, McGuire L, et al. A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples. Rheumatology (Oxford). 2008; 47: 1559-1463.
4. Beijer S, Kempen GI, Pijls-Johannesma MC, et al. Determinants of overall quality of life in preterminal cancer patients. Int J Cancer. 2008; 123: 232-235.
5. Dagnelie PC, Pijls-Johannesma MC, Lambin P, et al. Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy. Ann Oncol. 2007; 18: 940-944.
6. Minderhoud IM, Oldenburg B, van Dam PS, et al. High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. Am J Gastroenterol. 2003; 98: 1088-1093.
7. Russel M,. Data management of the South Limburg Inflammatory Bowel Disease Registry 'IBD South Limburg.'. Thesis. Incidence, risk factors and quality of life in IBD 1997. ISBN 90-9010684-7: 49-57.
8. Romberg-Camps MJ, Hesselink-van de Kruijs MA, Schouten L, et al. Inflammatory bowel disease in South Limburg (the Netherlands) 1991-2002: incidence, diagnostic delay, and seasonal variations in onset of symptoms. Results of a population based study, the IBD-South Limburg cohort. JCC. 2009; 3: 115-124.
9. Romberg-Camps MJ, Dagnelie PC, Kester AD, et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol. 2009; 104: 371-383.
10. Russel MG, Dorant E, Volovics A, et al. High incidence of inflammatory bowel disease in The Netherlands: results of a prospective study. The South Limburg IBD Study Group. Dis Colon Rectum. 1998; 41: 33-40.
11. Lennard Jones JE,. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989; s170: 2-6.
12. Geboes K, Colombel JF, Greenstein A, et al. Indeterminate colitis: a review of the concept-what's in a name? Inflamm Bowel Dis. 2008; 14: 850-857.
13. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000; 6: 8-15.
14. Hoie O, Wolters F, Riis L, et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol. 2007; 102: 1692-1701.
15. Wolters FL, Russel MG, Sijbrandij J, et al. Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut. 2006; 55: 1124-1130.
16. Harvey RF, Bradshaw JM,. A simple index of Crohn's-disease activity. Lancet. 1980; 1: 514.
17. Sandler RS, Jordan MC, Kupper LL,. Development of a Crohn's index for survey research. J Clin Epidemiol. 1988; 41: 451-458.
18. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994; 330: 1841-1845.
19. Smets EM, Garssen B, Cull A, et al. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer. 1996; 73: 241-245.
20. Smets EM, Garssen B, Bonke B, et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995; 39: 315-325.
21. Russel MG, Pastoor CJ, Brandon S, et al. Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion. 1997; 58: 282-288.
22. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989; 96: 804-810. (Pubitemid 19057603)
23. McHorney CA, Ware JE Jr, Lu JF, et al. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994; 32: 40-66.
24. Ware JE Jr, Sherbourne CD,. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30: 473-483.
25. van Tulder MW, Aaronson NK, Bruning PF,. The quality of life of long-term survivors of Hodgkin's disease. Ann Oncol. 1994; 5: 153-158.
26. Spinhoven P, Ormel J, Sloekers PP, et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997; 27: 363-370.
27. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67: 361-370.
28. Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002; 52: 69-77.
29. Schwarz R, Krauss O, Hinz A,. Fatigue in the general population. Onkologie. 2003; 26: 140-144.
30. Statacorp. Stata Statistical Software: Release 8.2. College Station, TX: Stata, 2005.
31. Lawrie SM, Manders DN, Geddes JR, et al. A population-based incidence study of chronic fatigue. Psychol Med. 1997; 27: 343-353.
32. Walker EA, Katon WJ, Jemelka RP,. Psychiatric disorders and medical care utilization among people in the general population who report fatigue. J Gen Intern Med. 1993; 8: 436-440.
33. Bates DW, Schmitt W, Buchwald D, et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med. 1993; 153: 2759-2765.
34. Watt T, Groenvold M, Bjorner JB, et al. Fatigue in the Danish general population. Influence of sociodemographic factors and disease. J Epidemiol Community Health. 2000; 54: 827-833.
35. van Tubergen A, Coenen J, Landewe R, et al. Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis Rheum. 2002; 47: 8-16.
36. Rupp I, Boshuizen HC, Jacobi CE, et al. Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Rheum. 2004; 51: 578-585. (Pubitemid 39056245)
37. Barendregt PJ, Visser MR, Smets EM, et al. Fatigue in primary Sjogren's syndrome. Ann Rheum Dis. 1998; 57: 291-295.
38. Unal G, de Boer JB, Borsboom GJ, et al. A psychometric comparison of health-related quality of life measures in chronic liver disease. J Clin Epidemiol. 2001; 54: 587-596.
39. Hagelin CL, Wengstrom Y, Runesdotter S, et al. The psychometric properties of the Swedish Multidimensional Fatigue Inventory MFI-20 in four different populations. Acta Oncol. 2007; 46: 97-104.
40. Visser MR, Smets EM,. Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer. 1998; 6: 101-108.
41. Holzner B, Kemmler G, Greil R, et al. The impact of hemoglobin levels on fatigue and quality of life in cancer patients. Ann Oncol. 2002; 13: 965-973.
42. Gasche C, Lomer MC, Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004; 53: 1190-1197.
43. Minderhoud IM, Samsom M, Oldenburg B,. Crohn's disease, fatigue, and infliximab: is there a role for cytokines in the pathogenesis of fatigue? World J Gastroenterol. 2007; 13: 2089-2093.
44. Carlsson E, Bosaeus I, Nordgren S,. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr. 2003; 22: 445-452.
45. Kalaitzakis E, Carlsson E, Josefsson A, et al. Quality of life in short-bowel syndrome: impact of fatigue and gastrointestinal symptoms. Scand J Gastroenterol. 2008; 43: 1057-1065.
46. Hauser W, Dietz N, Steder-Neukamm U, et al. Biopsychosocial determinants of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis. Inflamm Bowel Dis. 2004; 10: 399-407.
47. Bjornsson E, Simren M, Olsson R, et al. Fatigue in patients with primary sclerosing cholangitis. Scand J Gastroenterol. 2004; 39: 961-968. (Pubitemid 39388460)
48. Loftus EV, Feagan BG, Colombel JF, et al. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial. Am J Gastroenterol. 2008; 103: 3132-3141.
49. Nordin K, Pahlman L, Larsson K, et al. Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J Gastroenterol. 2002; 37: 450-457.
50. Kurina LM, Goldacre MJ, Yeates D, et al. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health. 2001; 55: 716-720.
51. Guthrie E, Jackson J, Shaffer J, et al. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol. 2002; 97: 1994-1999.
52. McKegney FP, Gordon RO, Levine SM,. A psychosomatic comparison of patients with ulcerative colitis and Crohn's disease. Psychosom Med. 1970; 32: 153-166.
53. Ondersma SJ, Lumley MA, Corlis ME, et al. Adolescents with inflammatory bowel disease: the roles of negative affectivity and hostility in subjective versus objective health. J Pediatr Psychol. 1997; 22: 723-738.
54. Helzer JE, Chammas S, Norland CC, et al. A study of the association between Crohn's disease and psychiatric illness. Gastroenterology. 1984; 86: 324-330.
55. Tarter RE, Switala J, Carra J, et al. Inflammatory bowel disease: psychiatric status of patients before and after disease onset. Int J Psychiatry Med. 1987; 17: 173-181.
56. Walker EA, Gelfand MD, Gelfand AN, et al. The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease. Gen Hosp Psychiatry. 1996; 18: 220-229.
57. Engstrom I, Lindquist BL,. Inflammatory bowel disease in children and adolescents: a somatic and psychiatric investigation. Acta Paediatr Scand. 1991; 80: 640-647.
58. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med. 2004; 66: 79-84.
59. Simren M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002; 97: 389-396.
60. Petrak F, Hardt J, Clement T, et al. Impaired health-related quality of life in inflammatory bowel diseases: psychosocial impact and coping styles in a national German sample. Scand J Gastroenterol. 2001; 36: 375-382.
61. Bernklev T, Jahnsen J, Aadland E, et al. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol. 2004; 39: 365-373.
62. Janke KH, Raible A, Bauer M, et al. Questions on life satisfaction (FLZM) in inflammatory bowel disease. Int J Colorectal Dis. 2004; 19: 343-353.
63. Blondel-Kucharski F, Chircop C, Marquis P, et al. Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol. 2001; 96: 2915-2920.
64. Bernklev T, Jahnsen J, Lygren I, et al. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis. 2005; 11: 909-918.
65. Han SW, McColl E, Barton JR, et al. Predictors of quality of life in ulcerative colitis: the importance of symptoms and illness representations. Inflamm Bowel Dis. 2005; 11: 24-34.
66. Pizzi LT, Weston CM, Goldfarb NI, et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006; 12: 47-52.
67. Casellas F, Lopez-Vivancos J, Badia X, et al. Influence of inflammatory bowel disease on different dimensions of quality of life. Eur J Gastroenterol Hepatol. 2001; 13: 567-572.
68. Sewitch MJ, Abrahamowicz M, Bitton A, et al. Psychological distress, social support, and disease activity in patients with inflammatory bowel disease. Am J Gastroenterol. 2001; 96: 1470-1479.
69. Casellas F, Arenas JI, Baudet JS, et al. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis. 2005; 11: 488-496.
70. Walker EA, Gelfand AN, Gelfand MD, et al. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med. 1995; 25: 1259-1267.
71. Casellas F, Lopez-Vivancos J, Casado A, et al. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res. 2002; 11: 775-781.
72. Porcelli P, Leoci C, Guerra V,. A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. Scand J Gastroenterol. 1996; 31: 792-796.
73. Hjortswang H, Jarnerot G, Curman B, et al. The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis. Eur J Gastroenterol Hepatol. 2003; 15: 1011-1020.
74. Graff LA, Walker JR, Lix L, et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol. 2006; 4: 1491-1501.
75. Saibeni S, Cortinovis I, Beretta L, et al. Gender and disease activity influence health-related quality of life in inflammatory bowel diseases. Hepatogastroenterology. 2005; 52: 509-515.
76. Faubion WA Jr, Loftus EV Jr, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001; 121: 255-260.
77. Bernklev T, Jahnsen J, Schulz T, et al. Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis. Eur J Gastroenterol Hepatol. 2005; 17: 1037-1045. (Pubitemid 41423996)
78. Minderhoud IM, Oldenburg B, Wismeijer JA, et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci. 2004; 49: 469-474.
79. Tanaka M, Kazuma K,. Ulcerative colitis: factors affecting difficulties of life and psychological well being of patients in remission. J Clin Nurs. 2005; 14: 65-73.
80. Smolen DM, Topp R,. Coping methods of patients with inflammatory bowel disease and prediction of perceived health, functional status, and well-being. Gastroenterol Nurs. 1998; 21: 112-118.
81. Moskovitz DN, Maunder RG, Cohen Z, et al. Coping behavior and social support contribute independently to quality of life after surgery for inflammatory bowel disease. Dis Colon Rectum. 2000; 43: 517-521.
82. van der Zaag-Loonen HJ, Grootenhuis MA, Last BF, et al. Coping strategies and quality of life of adolescents with inflammatory bowel disease. Qual Life Res. 2004; 13: 1011-1019.
83. Thirlby RC, Sobrino MA, Randall JB,. The long-term benefit of surgery on health-related quality of life in patients with inflammatory bowel disease. Arch Surg. 2001; 136: 521-527.
84. Thirlby RC, Land JC, Fenster LF, et al. Effect of surgery on health-related quality of life in patients with inflammatory bowel disease: a prospective study. Arch Surg. 1998; 133: 826-832.